Efficacy and safety analysis of the use of ibrutinib associated with rituximab for the first-line treatment of patients with chronic lymphocytic leukaemia.
Saved in:
| Title: | Efficacy and safety analysis of the use of ibrutinib associated with rituximab for the first-line treatment of patients with chronic lymphocytic leukaemia. |
|---|---|
| Authors: | Nascimento AD; Universidade de Brasilia, Distrito Federal, Brazil; Ministério da Saúde, Distrito Federal, Brazil. Electronic address: aline.donascimento@saude.gov.br., Curado DDSP; Universidade de Brasilia, Distrito Federal, Brazil; Ministério da Saúde, Distrito Federal, Brazil., Montezuma T; Universidade de Brasilia, Distrito Federal, Brazil; Hospital Alemão Oswaldo Cruz, São Paulo, Brazil., Barbosa WB; Universidade de Brasilia, Distrito Federal, Brazil; Ministério da Saúde, Distrito Federal, Brazil., Machado-Rugolo J; Universidade de Brasilia, Distrito Federal, Brazil; Hospital das Clínicas da Faculdade de Medicina de Botucatu, Botucatu, Brazil; Universidade de Sorocaba, Sorocaba, Brazil., Fachi MM; Universidade de Brasilia, Distrito Federal, Brazil; Hospital Alemão Oswaldo Cruz, São Paulo, Brazil. |
| Source: | Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2026 Jan-Mar; Vol. 48 (1), pp. 106234. Date of Electronic Publication: 2025 Dec 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Editora Ltda Country of Publication: Brazil NLM ID: 101725732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2531-1387 (Electronic) Linking ISSN: 25311379 NLM ISO Abbreviation: Hematol Transfus Cell Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2531-1387 |
|---|---|
| DOI: | 10.1016/j.htct.2025.106234 |
